Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Cytometry. Part B, Clinical Cytometry|November 27, 2014
Complexity and challenges in defining myeloid-derived suppressor cellsVera Damuzzo, Laura Pinton, Giacomo Desantis, et al.Cytometry. Part B, Clinical Cytometry|December 16, 2014
Complexity and challenges in defining myeloid-derived suppressor cellsVera Damuzzo, Laura Pinton, Giacomo Desantis, et al.Current Opinion in Pharmacology|July 21, 2009
Therapeutic targeting of myeloid-derived suppressor cellsStefano Ugel, Federica Delpozzo, Giacomo Desantis, et al.The Journal of Experimental Medicine|April 30, 2014
PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activationMuhammad Zaeem Noman, Giacomo Desantis, Bassam Janji, et al.Cancer Metastasis Reviews|January 27, 2011
Myeloid cell diversification and complexity: an old concept with new turns in oncologyMariacristina Chioda, Elisa Peranzoni, Giacomo Desantis, et al.Bone Marrow Transplantation|April 9, 2022
CD14 positive cells accelerate hematopoietic stem cell engraftmentAlice Pievani, Valentina Granata, Giacomo Desantis, et al.Cell Reports|September 11, 2012
Immune tolerance to tumor antigens occurs in a specialized environment of the spleenStefano Ugel, Elisa Peranzoni, Giacomo Desantis, et al.Stem Cell Reports|March 24, 2017
Efficient Ex Vivo Engineering and Expansion of Highly Purified Human Hematopoietic Stem and Progenitor Cell Populations for Gene TherapyErika Zonari, Giacomo Desantis, Carolina Petrillo, et al.EMBO Molecular Medicine|August 30, 2021
Myeloid cell-based delivery of IFN-γ reprograms the leukemia microenvironment and induces anti-tumoral immune responsesAdele Mucci, Gabriele Antonarelli, Carolina Caserta, et al.Leukemia|August 28, 2023
miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual diseaseCarolina Caserta, Silvia Nucera, Matteo Barcella, et al.Pageof 2